Biogen Idec Total Assets:
10.16B for March 31, 2013Biogen Idec Historical Total Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 10.16B |
| Dec. 31, 2012 | 10.13B |
| Sept. 30, 2012 | 9.631B |
| June 30, 2012 | 9.162B |
| March 31, 2012 | 9.114B |
| Dec. 31, 2011 | 9.050B |
| Sept. 30, 2011 | 8.802B |
| June 30, 2011 | 8.622B |
| March 31, 2011 | 8.294B |
| Dec. 31, 2010 | 8.092B |
| Sept. 30, 2010 | 7.394B |
| June 30, 2010 | 7.502B |
| March 31, 2010 | 8.217B |
| Dec. 31, 2009 | 8.552B |
| Sept. 30, 2009 | 9.026B |
| June 30, 2009 | 8.777B |
| March 31, 2009 | 8.575B |
| Dec. 31, 2008 | 8.479B |
About Total Assets
The sum of all current and long-term assets held by a company. An asset is any item with economic value that is held by a company.
Learn More
BIIB Total Assets Benchmarks
| Companies | |
|---|---|
| Elan | 1.614B |
| Novartis | 121.01B |
| Celgene Corporation | 11.45B |
BIIB Total Assets Rankings
| Overall |
91st percentile 665 of 8002 |
| Sector |
94th percentile 37 of 684 in Healthcare |
| Industry |
97th percentile 5 of 248 in Biotechnology |
BIIB Total Assets Range, Past 5 Years
| Minimum | 7.394B | Sep 2010 |
| Maximum | 10.16B | Mar 2013 |
| Average | 8.755B |
